Hood River Capital Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73.3M | Buy |
533,023
+8,379
| +2% | +$1.15M | 1.02% | 35 |
|
|
2025
Q1 | $94.6M | Buy |
524,644
+11,918
| +2% | +$2.15M | 1.61% | 12 |
|
|
2024
Q4 | $80.3M | Buy |
512,726
+10,622
| +2% | +$1.66M | 1.19% | 28 |
|
|
2024
Q3 | $91.4M | Sell |
502,104
-18,989
| -4% | -$3.46M | 1.48% | 17 |
|
|
2024
Q2 | $95.7M | Buy |
521,093
+25,507
| +5% | +$4.68M | 1.98% | 9 |
|
|
2024
Q1 | $88.2M | Buy |
495,586
+37,073
| +8% | +$6.6M | 1.97% | 11 |
|
|
2023
Q4 | $56.9M | Sell |
458,513
-1,976
| -0.4% | -$245K | 1.56% | 18 |
|
|
2023
Q3 | $53.4M | Buy |
460,489
+8,033
| +2% | +$932K | 1.71% | 15 |
|
|
2023
Q2 | $53.1M | Buy |
452,456
+5,063
| +1% | +$594K | 1.58% | 22 |
|
|
2023
Q1 | $35.8M | Buy |
447,393
+20,514
| +5% | +$1.64M | 1.16% | 38 |
|
|
2022
Q4 | $33.8M | Buy |
426,879
+10,123
| +2% | +$802K | 1.23% | 32 |
|
|
2022
Q3 | $29M | Buy |
416,756
+7,745
| +2% | +$540K | 1.11% | 33 |
|
|
2022
Q2 | $26.9M | Buy |
409,011
+24,201
| +6% | +$1.59M | 1.07% | 36 |
|
|
2022
Q1 | $25.6M | Buy |
384,810
+159,083
| +70% | +$10.6M | 0.85% | 43 |
|
|
2021
Q4 | $15.8M | Sell |
225,727
-174
| -0.1% | -$12.2K | 0.47% | 68 |
|
|
2021
Q3 | $11.8M | Sell |
225,901
-8,866
| -4% | -$463K | 0.36% | 76 |
|
|
2021
Q2 | $16M | Sell |
234,767
-3,115
| -1% | -$212K | 0.48% | 73 |
|
|
2021
Q1 | $18.3M | Sell |
237,882
-23,240
| -9% | -$1.79M | 0.59% | 68 |
|
|
2020
Q4 | $15.7M | Buy |
261,122
+3,919
| +2% | +$235K | 0.52% | 77 |
|
|
2020
Q3 | $11.1M | Sell |
257,203
-25,008
| -9% | -$1.08M | 0.48% | 77 |
|
|
2020
Q2 | $11.7M | Buy |
+282,211
| New | +$11.7M | 0.52% | 76 |
|